Noveris Health Sciences Inc. is trading 12.5% up today at $2.25 on speculative trading and price normalization following a previous regulatory halt.
- The stock is extending a sharp rebound after recent double-digit swings and a March 2026 regulatory halt triggered by unusual price and volume activity.
- No new company filings or press releases have been issued in the last 24 hours to explain the current upward momentum.
- The move appears to be driven by market sentiment rather than fundamental news or fresh corporate developments.